- Investing Ideas
- /
- Semiconductors Healthcare Sector
Semiconductors Healthcare Sector
Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
CARGO Therapeutics
Market Cap: US$183.1m
A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.
CRGX
US$3.84
7D
-5.2%
1Y
-81.7%
Baird Medical Investment Holdings
Market Cap: US$182.5m
Together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China, Egypt, Indonesia, and the United States.
BDMD
US$5.14
7D
-3.9%
1Y
-53.7%
Voyager Therapeutics
Market Cap: US$181.5m
A biotechnology company, focuses on the human genetics for the cure of neurological diseases.
VYGR
US$3.19
7D
-2.7%
1Y
-62.8%
Stereotaxis
Market Cap: US$181.5m
Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
STXS
US$2.04
7D
-2.4%
1Y
-2.4%
Cardiff Oncology
Market Cap: US$181.0m
A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.
CRDF
US$2.67
7D
7.2%
1Y
-25.2%
Deltex Medical Group
Market Cap: US$180.6m
Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.
DTXM.F
US$0.095
7D
0%
1Y
n/a
Tiziana Life Sciences
Market Cap: US$180.6m
A biotechnology company, specializes in the development of transformative therapies for neurodegenerative and lung diseases in the United States.
TLSA
US$1.45
7D
-7.6%
1Y
128.3%
Quanterix
Market Cap: US$180.2m
A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
QTRX
US$4.28
7D
-20.1%
1Y
-76.1%
Utah Medical Products
Market Cap: US$179.5m
Provides medical devices for the healthcare industry worldwide.
UTMD
US$54.37
7D
0.8%
1Y
-21.5%
TuHURA Biosciences
Market Cap: US$179.1m
A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.
HURA
US$3.89
7D
2.4%
1Y
n/a
Fennec Pharmaceuticals
Market Cap: US$178.8m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$6.33
7D
3.6%
1Y
-9.3%
Anika Therapeutics
Market Cap: US$178.0m
A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.
ANIK
US$11.32
7D
-21.9%
1Y
-56.6%
Sight Sciences
Market Cap: US$176.8m
An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.
SGHT
US$3.28
7D
14.7%
1Y
-40.9%
Avacta Group
Market Cap: UK£132.3m
Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.
AVCT
UK£0.34
7D
3.0%
1Y
-22.0%
Eledon Pharmaceuticals
Market Cap: US$173.7m
Operates as a clinical stage biotechnology company.
ELDN
US$2.83
7D
-5.7%
1Y
13.0%
Spectral Medical
Market Cap: CA$239.5m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$0.81
7D
-2.4%
1Y
52.8%
OmniAb
Market Cap: US$171.3m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$1.52
7D
-0.7%
1Y
-66.5%
Atlantic International
Market Cap: US$171.0m
Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals.
ATLN
US$2.64
7D
-14.8%
1Y
n/a
Accuray
Market Cap: US$171.0m
Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.
ARAY
US$1.59
7D
16.9%
1Y
-5.9%
Liminatus Pharma
Market Cap: US$170.8m
Liminatus Pharma, LLC operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.
LIMN
US$6.50
7D
8.4%
1Y
-38.7%
DiaMedica Therapeutics
Market Cap: US$170.6m
A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.
DMAC
US$4.00
7D
4.2%
1Y
32.9%
Inhibikase Therapeutics
Market Cap: US$165.8m
Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.
IKT
US$2.12
7D
14.6%
1Y
6.5%
Inogen
Market Cap: US$165.1m
A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.
INGN
US$5.88
7D
-18.0%
1Y
-33.5%
LENSAR
Market Cap: US$164.9m
A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.
LNSR
US$14.18
7D
2.5%
1Y
241.7%
Organigram Global
Market Cap: CA$230.1m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.69
7D
8.3%
1Y
-35.2%
TriSalus Life Sciences
Market Cap: US$163.6m
Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics for improving outcomes for patients with difficult-to-treat liver and pancreatic cancers.
TLSI
US$4.90
7D
-5.8%
1Y
-47.8%
Procaps Group
Market Cap: US$163.6m
Develops, produces, and markets pharmaceutical solutions worldwide.
PROC.F
US$1.45
7D
0%
1Y
-43.8%
Inhibrx Biosciences
Market Cap: US$163.3m
A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.
INBX
US$10.84
7D
-2.3%
1Y
n/a
Development Technologies
Market Cap: US$163.2m
Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.
DVTC
US$7.77
7D
0%
1Y
n/a
Prime Medicine
Market Cap: US$162.3m
A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.
PRME
US$1.21
7D
-14.8%
1Y
-82.1%
ProQR Therapeutics
Market Cap: US$161.0m
A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.
PRQR
US$1.55
7D
-1.3%
1Y
-18.8%
Zentek
Market Cap: CA$224.3m
Engages in the research and development of graphene and related nanomaterials in Canada.
ZEN
CA$2.17
7D
0.5%
1Y
41.8%
hVIVO
Market Cap: UK£120.8m
Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.
HVO
UK£0.18
7D
-1.4%
1Y
-35.5%
AFT Pharmaceuticals
Market Cap: NZ$271.6m
Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.59
7D
-2.6%
1Y
-8.8%
Race Oncology
Market Cap: AU$246.7m
A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.
RAC
AU$1.42
7D
15.9%
1Y
-9.3%
Anteris Technologies Global
Market Cap: AU$246.7m
A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.
AVR
AU$6.84
7D
-2.0%
1Y
-66.1%